Differential regulation of insulin-like growth factor-binding protein-3 protease activity in MCF-7 breast cancer cells by estrogen and transforming growth factor-β1

Endocrinology

Volumn 141, Issue 9, 2000, Pages 3104-3110

  Salahifar, Houta ^a   Baxter, Robert C ^a   Martin, Janet L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN; FORSKOLIN; GROWTH INHIBITOR; INSULIN; PLATELET DERIVED GROWTH FACTOR; PROTEINASE; RETINOIC ACID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D;

ARTICLE; ASSAY; BINDING AFFINITY; BREAST CANCER; BREAST CARCINOGENESIS; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0034457886     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.9.7684     Document Type: Article

References (39)

1. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor
2. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
3. IGF binding proteins as modulators of IGF action
4. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: Correlation with estrogen receptor status
5. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
6. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
7. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery
8. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
9. Proteolytic modification of insulin-like growth factor-binding proteins: Comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes
10. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
11. Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells
12. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells
13. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
14. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
15. Molecular aspects of the insulin-like growth factor binding proteins
16. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor; reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action
17. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25 -kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3
18. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: Inhibition by IGFs does not require IGF-IGFBP interaction
19. Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities
20. Identification of insulin-like growth factor binding proteins in breast cancer cells
21. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
22. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7
23. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene
24. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
25. Inhibition of breast cancer growth by suramin
26. Anti-steroidal and antigrowth factor activities of anti-estrogens
27. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
28. Insulin-like growth factors, their binding proteins, and transforming growth factor-β1 in oxidant-arrested lung alveolar epithelial cells
29. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
30. 3 and its analogues
31. Transforming growth factor-β stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts
32. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
33. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
34. Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border
35. Vacuolar-type H+ATPases are functionally expressed in plasma membranes of human tumour cells
36. Increased sialic acid density in surface glycoprotein of transformed and malignant cells
37. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells
38. Growth factors in the regulation of pericellular proteolysis: A review
39. Cathepsin D in breast cancer: A tissue marker associated with metastasis